SingHealth Duke-NUS Academic Medical Centre
Parent institutions Duke-NUS Medical School, SingHealth
ROR: Yes
Works count: 1,458
Citations count: 30,530
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
2017 · Anthony B. El-Khoueiry, Bruno Sangro, et al. · The Lancet
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
2020 · Aymeric Silvin, Nicolas Chapuis, et al. · Cell
Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells
2019 · Zhaoyuan Liu, Yaqi Gu, et al. · Cell